BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19562472)

  • 1. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
    Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
    J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.
    Hobo W; Maas F; Adisty N; de Witte T; Schaap N; van der Voort R; Dolstra H
    Blood; 2010 Nov; 116(22):4501-11. PubMed ID: 20682852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.
    Planès R; BenMohamed L; Leghmari K; Delobel P; Izopet J; Bahraoui E
    J Virol; 2014 Jun; 88(12):6672-89. PubMed ID: 24696476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines.
    Dai B; Xiao L; Bryson PD; Fang J; Wang P
    Mol Ther; 2012 Sep; 20(9):1800-9. PubMed ID: 22588271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals.
    Granelli-Piperno A; Zhong L; Haslett P; Jacobson J; Steinman RM
    J Immunol; 2000 Dec; 165(11):6620-6. PubMed ID: 11086107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY; Park SH; Nam HJ; Choi DH; Sung YC
    J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10.
    Rodríguez-García M; Porichis F; de Jong OG; Levi K; Diefenbach TJ; Lifson JD; Freeman GJ; Walker BD; Kaufmann DE; Kavanagh DG
    J Leukoc Biol; 2011 Apr; 89(4):507-15. PubMed ID: 21097698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
    Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
    Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation.
    Hobo W; Novobrantseva TI; Fredrix H; Wong J; Milstein S; Epstein-Barash H; Liu J; Schaap N; van der Voort R; Dolstra H
    Cancer Immunol Immunother; 2013 Feb; 62(2):285-97. PubMed ID: 22903385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient nontoxic delivery of PD-L1 and PD-L2 siRNA into dendritic cell vaccines using the cationic lipid SAINT-18.
    Roeven MW; Hobo W; van der Voort R; Fredrix H; Norde WJ; Teijgeler K; Ruiters MH; Schaap N; Dolstra H
    J Immunother; 2015 May; 38(4):145-54. PubMed ID: 25839440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodeficiency virus-infected macaques and may contribute to T cell dysfunction and disease progression.
    Xu H; Wang X; Pahar B; Moroney-Rasmussen T; Alvarez X; Lackner AA; Veazey RS
    J Immunol; 2010 Dec; 185(12):7340-8. PubMed ID: 21059890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion.
    Van den Bergh JMJ; Smits ELJM; Berneman ZN; Hutten TJA; De Reu H; Van Tendeloo VFI; Dolstra H; Lion E; Hobo W
    Cancer Immunol Res; 2017 Aug; 5(8):710-715. PubMed ID: 28637876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
    Garcia-Bates TM; Palma ML; Shen C; Gambotto A; Macatangay BJC; Ferris RL; Rinaldo CR; Mailliard RB
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function.
    Jones D; Como CN; Jing L; Blackmon A; Neff CP; Krueger O; Bubak AN; Palmer BE; Koelle DM; Nagel MA
    PLoS Pathog; 2019 Mar; 15(3):e1007650. PubMed ID: 30870532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
    Pittet CL; Newcombe J; Prat A; Arbour N
    J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-tuned expression of programmed death 1 ligands in mature dendritic cells stimulated by CD40 ligand is critical for the induction of an efficient tumor specific immune response.
    Gu T; Zhu YB; Chen C; Li M; Chen YJ; Yu GH; Ge Y; Zhou SY; Zhou H; Huang Y; Qiu YH; Zhang XG
    Cell Mol Immunol; 2008 Feb; 5(1):33-9. PubMed ID: 18318992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice.
    Zhou J; Cheung AK; Tan Z; Wang H; Yu W; Du Y; Kang Y; Lu X; Liu L; Yuen KY; Chen Z
    J Clin Invest; 2013 Jun; 123(6):2629-42. PubMed ID: 23635778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine.
    Hassannia H; Ghasemi Chaleshtari M; Atyabi F; Nosouhian M; Masjedi A; Hojjat-Farsangi M; Namdar A; Azizi G; Mohammadi H; Ghalamfarsa G; Sabz G; Hasanzadeh S; Yousefi M; Jadidi-Niaragh F
    Immunology; 2020 Jan; 159(1):75-87. PubMed ID: 31587253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
    Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
    J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.